We are experts in life science, biotechnology and medical technology, but also related areas such as ICT, eHealth and big data. Through our services we strive to contribute to the development of breakthrough products that serve an unmet medical need. We commit ourselves to design the highest quality projects and be successful in securing funding to realize our clients’strategic and business objectives.
We secure your non-dilutive funding, including large scale European grants. We take on the full application process using our proven approach.
We raise dilutive funding through our investor network, ideally suited to co‐finance your grant programs and fulfil your later stage capital needs.
400+ Mln euro raised
900+ Network partners
Team of consultants with scientific and academic excellence (PhD, MD)
Consultants with relevant commercial experience in translating research into commercial products
We use a step-wise approach and take full control over the application process, while keeping you informed about the process at all time. Catalyze become a true partner and is in the driver seat to maximize your funding results.
We define the best project concepts and solve any missing links to increase your chance of getting funded.
We design high quality work packages, including feasible and ealistic timelines, deliverables and milestones.
Weprovide detailed budget planning and draft the budgets for your project, including the budget of consortium members.
We facilitate grant and consortium agreements to ensure you can successfully start your project, including IP and exploitation articles. We can also provide project management services during your project.
We offer a network of >800 partners for consortium building. We actively seek and approach partners to join your project.
We take on the full writing of your proposals, and offer our strong knowledge to score on exploitation, impact, implementation and dissemination.
We coordinate the entire process, from project intake to successful submission. We also represent your consortium towards the funding agencies..
What client say about us
Amsterdam, February 22, 2018– Closely succeeding the successful expansion to Copenhagen, Denmark, Catalyze has now also expanded its operations to Switzerland. This presents the next step of the company’s international growth plan. Switzerland is home to many pharmaceutical and diagnostic companies and represents a strong eco-system in Zurich, Lausanne and Basel, consisting of many start-ups,…
Catalyze makes successful move with European expansion Amsterdam, February 14, 2018– Catalyze has opened the doors to their new office in Copenhagen, Denmark. The new office will be at the Copenhagen Bio Science Park (COBIS), close to many companies active in the field of Life Sciences. From this office, Catalyze will be able to better…
Amsterdam, November 1st, 2017. The management of Catalyze is happy to announce the appointment of Quirein te Roller as its Commercial Director. Quirein’s main focus will be on further professionalizing the Sales and Business Development Organization both in The Netherlands and abroad. Furthermore, Quirein will lead the strengthening of our Strategic Funding Unit (SFU) and…